Kanghong Pharmaceutical (002773.SZ): "KH812 Intravitreal Injection" Drug Clinical Trial Approved.

Zh tng Cijng APP news, Kanghong Pharmaceuticals (002773.SZ) released an announcement. Recently, the company's wholly-owned subsidiary, Chengdu Kanghong Biotechnology Co., Ltd. (hereinafter referred to as "Kanghong Biotechnology"), received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration, involving the product: "KH812 intraocular injection solution".